Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) is expected to report third quarter earnings results, after market close, on Monday 9th November 2020.
Analysts polled by Thomson Reuters anticipate third quarter loss of $ 0.49 per share from revenue of $ 3.00 million.
Looking ahead, the full year loss are expected at $ 2.17 per share on the revenues of $ 11.16 million.
Previous Quarter Performance
Arcturus Therapeutics Holdings Inc. recorded loss for the second quarter of $ 0.55 per share, from the revenue of $ 2.32 million. The consensus estimates are loss of $ 0.55 per share from $ 3.54 million in revenue. The top line results fell short of analysts by $ 1.22 million or 34.46 percent.
Stock Performance
On Friday, shares of Arcturus Therapeutics Holdings Inc. has traded high as $ 64.46 and has cracked $ 59.66 on the downward trend, reaching $ 63.36 with volume of 379.70 thousand shares.
According to the previous trading day, closing price of $ 63.36, representing a 619.86 % increase from the 52 week low of $ 8.51 and a 7.52 % decrease over the 52 week high of $ 66.24.
The company has a market capital of $ 1.55 billion and is part of the Financial sector and REIT – Office industry.
Recent Analyst recommendations
- On 6th October 2020, initiated by Citigroup at Buy rating, with $ 65.00 target price.
